
|Articles|August 26, 2016
Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top news of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/biosimilar-naming-convention-debate-highlights-spe" target="_blank">View the story "Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Adults With Schizophrenia Remain Stable When Transitioning from Atypical Antipsychotic to Cobenfy
4
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
5






































































































































